CAS NO: | 205256-55-9 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | CT52923 is a selective, orally activeplatelet-derived growth factor receptor (PDGFR)antagonist. CT52923 also is an ATP-competitive inhibitor. CT52923 can be used for the research variety of pathological diseases, including atherosclerosis, glomerulonephritis, liver cirrhosis, pulmonary fibrosis, andcancer[1]. | ||||||||
体外研究 (In Vitro) | CT52923 抑制 PDGFRs 和干细胞因子受体,IC50值为 100 至 200 nM[1]。 Cell Migration Assay[1]
| ||||||||
体内研究 (In Vivo) | CT52923(口服;5、15、30 和 50 mg/kg;每日两次)可显著抑制大鼠颈动脉损伤后内膜新生的形成[1]。
| ||||||||
分子量 | 467.54 | ||||||||
性状 | Solid | ||||||||
Formula | C23H25N5O4S | ||||||||
CAS 号 | 205256-55-9 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |